1.Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, Beijing 100191, China
2.Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing 100191, China
3.Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, Beijing 100191, China
4.Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110134, China
5.State Key Laboratory of Natural and Biomimetic Drugs, Ministry of Education, Key Laboratory of Cell Proliferation and Differentiation, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Center for Life Sciences, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing 100871, China
6.Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing 100021, China
7.Research Center for Cardiopulmonary Rehabilitation, University of Health and Rehabilitation Sciences Qingdao Hospital (Qingdao Municipal Hospital), School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao 266113, Shandong, China
8.Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Third Hospital, Beijing 100191, China
Author bio:
* Dong-Yu Zhao zhaodongyu@bjmu.edu.cn
Er-Dan Dong donged@bjmu.edu.cn
Yu-Hui Wang wangyuhui2009@bjmu.edu.cn
Xun-De Xian xianxunde@bjmu.edu.cn
Funds:
the National Natural Science Foundation of China(82270479;82070460);the Beijing Natural Science Foundation(7242084);the National Key Research and Development Program of China from the Ministry of Science and Technology(2021YFF0702802)
Guo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, 等. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease[J]. Military Medical Research, 2025,12(9):1329-1349.
Guo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, et al. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease[J]. Military Medical Research, 2025, 12(9): 1329-1349.
Guo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, 等. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease[J]. Military Medical Research, 2025,12(9):1329-1349. DOI: 10.1186/s40779-025-00594-3.
Guo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, et al. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease[J]. Military Medical Research, 2025, 12(9): 1329-1349. DOI: 10.1186/s40779-025-00594-3.
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease
Advanced multifunctional nano-delivery platform focusing on treating diseases related to lipid metabolism via targeted intervention in various lipid metabolic processes
RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis
钢拱桥极限承载力的综合三因素检算方法
840D车轮辐板孔裂纹扩展速率的统计分析
既有线钢桁梁桥横向刚度加固技术
相关作者
Xun-De Xian
Yu-Hui Wang
Er-Dan Dong
Dong-Yu Zhao
Ying Sun
Kai Yan
Yi Zhang
Yan-Qi Han
相关机构
Translational Medicine Center, Beijing Chest Hospital, Capital Medical University
Children Hospital of Fudan University
Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences &Peking Union Medical College
Department of Neurosurgery, Renmin Hospital of Wuhan University